-
Pharmaceutical sector's investment in Canada chronically underreported: KPMG
OTTAWA | For the third consecutive year, a KPMG study commissioned by Canada's Research-Based Pharmaceutical Companies (Rx&D) has determined that research and development investments made by Canada's innovative pharmaceutical sector continue to be consistently underreported, by approximately 34% for 2012.